LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

LLY

710.61

+0.3%↑

JNJ

179.04

+0.08%↑

ABBV

210.25

+0.41%↑

UNH

306.92

+1.28%↑

AZN

80.93

+0.65%↑

Search

Achieve Life Sciences Inc

Cerrado

2.91 0.69

Resumen

Variación precio

24h

Actual

Mínimo

2.86

Máximo

3.05

Métricas clave

By Trading Economics

Ingresos

109K

-13M

Empleados

25

EBITDA

-16K

-12M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+405.19% upside

Dividendos

By Dow Jones

Próximas Ganancias

6 nov 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

7.8M

136M

Apertura anterior

2.22

Cierre anterior

2.91

Puntuación técnica

By Trading Central

Confianza

Weak Bullish Evidence

Achieve Life Sciences Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

22 ago 2025, 23:09 UTC

Adquisiciones, fusiones, absorciones

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 4th Update

22 ago 2025, 22:02 UTC

Adquisiciones, fusiones, absorciones

Agreement Could Also Lead to Deeper Collaboration Between CSX, BNSF

22 ago 2025, 22:02 UTC

Adquisiciones, fusiones, absorciones

Some Analysts Say Agreement Suggests Lack of Confidence in Merger

22 ago 2025, 22:02 UTC

Adquisiciones, fusiones, absorciones

CSX, BNSF Intermodal Pact Draws Competing Views on Merger Possibility

22 ago 2025, 22:02 UTC

Adquisiciones, fusiones, absorciones

CSX, BNSF Pact Sparks Debate on Whether Another Rail Merger Is Approaching -- Analysis

22 ago 2025, 22:02 UTC

Adquisiciones, fusiones, absorciones

Pact Could Show Regulators That Transcontinental Service Can Come Without Merger

22 ago 2025, 21:23 UTC

Charlas de Mercado

Moody's Lowers Outlook on Austria to Negative From Stable -- Market Talk

22 ago 2025, 21:18 UTC

Charlas de Mercado

US Economic Growth Seen Slowing This Year -- Market Talk

22 ago 2025, 21:18 UTC

Adquisiciones, fusiones, absorciones

U.S. Takes 10% Stake in Intel -- Barrons.com

22 ago 2025, 21:03 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

22 ago 2025, 21:03 UTC

Charlas de Mercado

Mexican Stocks Close At Record High -- Market Talk

22 ago 2025, 20:58 UTC

Charlas de Mercado

US General Government Deficit Expected to Rise in 2026, 2027 -- Market Talk

22 ago 2025, 20:57 UTC

Adquisiciones, fusiones, absorciones

Intel: Government's Investment in Intel Will Be a Passive Ownership, With No Bd Representation or Other Governance or Info Rights >INTC

22 ago 2025, 20:57 UTC

Adquisiciones, fusiones, absorciones

Intel: Government Also Agrees to Vote With the Company's Bd of Directors on Matters Requiring Shareholder Approval, With Limited Exceptions >INTC

22 ago 2025, 20:57 UTC

Adquisiciones, fusiones, absorciones

Intel: Government Equity Stake Will Be Funded by Remaining $5.7B in Grants Previously Awarded, But Not Yet Paid, Under U.S. CHIPS and Science Act and $3.2B Awarded as Part of Secure Enclave Program >INTC

22 ago 2025, 20:57 UTC

Adquisiciones, fusiones, absorciones

Intel: Government Agrees to Purchase 433.3M Primary Shrs of Intel Common Stk at a Price of $20.47 per Shr, Equivalent to a 9.9% Stake in Co >INTC

22 ago 2025, 20:57 UTC

Adquisiciones, fusiones, absorciones

Intel: U.S. Government to Make $8.9B Investment in Intel Common Stk as Co Builds Upon Its More Than $100B Expansion of Resilient Semiconductor Supply Chain >INTC

22 ago 2025, 20:57 UTC

Adquisiciones, fusiones, absorciones

Intel: Intel and Trump Admin Reach Historic Agreement to Accelerate Amer Technology and Manufacturing Leadership

22 ago 2025, 20:56 UTC

Ganancias

These Stocks Moved the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22 ago 2025, 20:55 UTC

Ganancias

These Stocks Are Moving the Most Today: Nvidia, Builders FirstSource, Zoom, Intuit, Workday, BJ's, Ubiquiti, and More -- Barrons.com

22 ago 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Tech, Media & Telecom Roundup: Market Talk

22 ago 2025, 20:50 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Basic Materials Roundup: Market Talk

22 ago 2025, 20:41 UTC

Adquisiciones, fusiones, absorciones

U.S. Has 10% Stake in Intel, Lutnick Says -- Barrons.com

22 ago 2025, 20:24 UTC

Adquisiciones, fusiones, absorciones

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 3rd Update

22 ago 2025, 20:16 UTC

Adquisiciones, fusiones, absorciones

CSX and Warren Buffett's BNSF Made News. Why Investors Are Disappointed. -- Barrons.com

22 ago 2025, 19:19 UTC

Charlas de Mercado

Boeing to Restart Talks With Defense Workers' Union Monday -- Market Talk

22 ago 2025, 19:10 UTC

Charlas de Mercado

Oil Futures Gain as Russia-Ukraine Peace Seems Distant -- Market Talk

22 ago 2025, 19:06 UTC

Charlas de Mercado

U.S. Natural Gas Extends Losses as Summer Nears an End -- Market Talk

22 ago 2025, 19:03 UTC

Charlas de Mercado

Lower Borrowing Rates Elusive Even if Fed Cuts -- Market Talk

22 ago 2025, 18:52 UTC

Adquisiciones, fusiones, absorciones

Trump Says U.S. Will Take Nearly 10% Equity Stake in Intel -- 2nd Update

Comparación entre iguales

Cambio de precio

Achieve Life Sciences Inc previsión

Precio Objetivo

By TipRanks

405.19% repunte

Estimación a 12 Meses

Media 14.6 USD  405.19%

Máximo 20 USD

Mínimo 10 USD

De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Achieve Life Sciences Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

5 ratings

5

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

2.325 / 2.64Soporte y Resistencia

Corto Plazo

Weak Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Weak Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Achieve Life Sciences Inc

Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.